Virulence 2026

1 papers

Top Research Directions

The 6 research directions with Virulence 2026 papers, ranked by paper count, next to 2025. Share is the fraction of the edition’s papers in the direction.

#Direction20262025Share 2026Share 20252025 rank
1Countering the Molecular Mechanisms of Antibiotic Resistance11100.0%50.0%1
2Establishing Causality with Fecal Microbiota Transplantation10100.0%0.0%—
3How Antibiotic Induced Dysbiosis Drives Systemic Disease10100.0%0.0%—
4Mapping Immune Landscapes with Multi-Parameter Flow Cytometry10100.0%0.0%—
5Microbial Metabolite Signaling for Systemic Homeostasis10100.0%0.0%—
6Profiling Microbial Communities via Amplicon Sequencing10100.0%0.0%—

Download all directions as CSV

Institutions

Institutions credited by Virulence 2026 papers: a paper credits every institution named in its affiliations, once. 1 institutions share 1 credited papers.

#InstitutionPapersShare20252025 rank
1Inner Mongolia University 1100.0%0—

Download all institutions as CSV

About this data

Papers. Virulence 2026 lists 1 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers. Comparisons with 2025 use shares, since the edition went from 2 to 1 papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 1 of 1 papers (100.0%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-19 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “Virulence 2026”, https://lacuna.tiptreesystems.com/venue/virulence/2026.

Papers

Title
Gut microbiota-driven IL-17A production by hepatic γδ T cells enhances neutrophil defense against systemic Staphylococcus aureus infection